Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CLCN1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | MTIF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NFKB2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | SPAG1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | VIP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TNKS2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | DDIT4L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | RRAS | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TAS2R50 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | TMEM68 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |